# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011579
Filing Date
2024-08-08
Accepted
2024-08-08 16:00:35
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | glyc-20240630x10q.htm iXBRL | 10-Q | 1245004
2 | EX-31.1 | glyc-20240630xex31d1.htm | EX-31.1 | 16952
3 | EX-31.2 | glyc-20240630xex31d2.htm | EX-31.2 | 16768
4 | EX-32.1 | glyc-20240630xex32d1.htm | EX-32.1 | 9431
| Complete submission text file | 0001558370-24-011579.txt |  | 5344472

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | glyc-20240630.xsd | EX-101.SCH | 36376
6 | EX-101.CAL | glyc-20240630_cal.xml | EX-101.CAL | 33419
7 | EX-101.DEF | glyc-20240630_def.xml | EX-101.DEF | 174827
8 | EX-101.LAB | glyc-20240630_lab.xml | EX-101.LAB | 354174
9 | EX-101.PRE | glyc-20240630_pre.xml | EX-101.PRE | 299989
67 | EXTRACTED XBRL INSTANCE DOCUMENT | glyc-20240630x10q_htm.xml | XML | 778636

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 241188012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)